SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001558370-23-005974
Filing Date
2023-04-14
Accepted
2023-04-14 17:00:43
Documents
20

Document Format Files

Seq Description Document Type Size
1 PRE 14A iova-20230606xpre14a.htm   iXBRL PRE 14A 1953954
2 GRAPHIC iova-20230606xpre14a002.jpg GRAPHIC 15019
3 GRAPHIC iova-20230606xpre14a008.jpg GRAPHIC 38039
4 GRAPHIC iova-20230606xpre14a019.jpg GRAPHIC 44030
5 GRAPHIC iova-20230606xpre14a020.jpg GRAPHIC 36226
6 GRAPHIC iova-20230606xpre14a022.jpg GRAPHIC 185490
7 GRAPHIC iova-20230606xpre14a023.jpg GRAPHIC 94588
  Complete submission text file 0001558370-23-005974.txt   4488826

Data Files

Seq Description Document Type Size
8 EX-101.SCH iova-20230606.xsd EX-101.SCH 5760
9 EX-101.DEF iova-20230606_def.xml EX-101.DEF 7874
10 EX-101.LAB iova-20230606_lab.xml EX-101.LAB 13183
11 EX-101.PRE iova-20230606_pre.xml EX-101.PRE 6870
14 EXTRACTED XBRL INSTANCE DOCUMENT iova-20230606xpre14a_htm.xml XML 547535
Mailing Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36860 | Film No.: 23821891
SIC: 2836 Biological Products, (No Diagnostic Substances)